H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine H-index 98 Citations 34,581 542 World Ranking 4203 National Ranking 47

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Endocrinology
  • Diabetes mellitus

His scientific interests lie mostly in Internal medicine, Endocrinology, Diabetes mellitus, Adiponectin and Insulin. His Internal medicine research incorporates themes from Tendon and Streptozotocin. His Endocrinology study combines topics in areas such as Growth factor and Insulin-like growth factor.

His Adiponectin research incorporates elements of Adipose tissue, Prospective cohort study and Leptin. His study in Insulin is interdisciplinary in nature, drawing from both Blood sampling, Chemotherapy and Somatostatin. His work carried out in the field of Type 1 diabetes brings together such families of science as Gastroenterology, Type 2 diabetes and Kidney metabolism.

His most cited work include:

  • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). (1544 citations)
  • The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth (741 citations)
  • Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure (519 citations)

What are the main themes of his work throughout his whole career to date?

Internal medicine, Endocrinology, Diabetes mellitus, Insulin and Adiponectin are his primary areas of study. His Internal medicine study frequently draws connections between related disciplines such as Cardiology. Allan Flyvbjerg combines subjects such as Insulin-like growth factor-binding protein and Growth factor with his study of Endocrinology.

As part of his studies on Diabetes mellitus, Allan Flyvbjerg often connects relevant areas like Disease. The concepts of his Adiponectin study are interwoven with issues in Body mass index, Adipose tissue, Metabolic syndrome and Adipokine. He interconnects Muscle hypertrophy and Urinary system in the investigation of issues within Kidney.

He most often published in these fields:

  • Internal medicine (98.68%)
  • Endocrinology (83.86%)
  • Diabetes mellitus (31.63%)

What were the highlights of his more recent work (between 2011-2021)?

  • Internal medicine (98.68%)
  • Endocrinology (83.86%)
  • Diabetes mellitus (31.63%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Internal medicine, Endocrinology, Diabetes mellitus, Adiponectin and Cardiology. The study incorporates disciplines such as Type 1 diabetes and Type 2 diabetes in addition to Internal medicine. His Endocrinology study frequently draws connections between adjacent fields such as Insulin-like growth factor.

His Diabetes mellitus study combines topics from a wide range of disciplines, such as Periodontitis, Disease and Immunology. Allan Flyvbjerg works mostly in the field of Adiponectin, limiting it down to topics relating to Body mass index and, in certain cases, Obesity. His work on Coronary artery disease as part of general Cardiology research is frequently linked to Osteoprotegerin, bridging the gap between disciplines.

Between 2011 and 2021, his most popular works were:

  • Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)—a multicentre, double‐blind, randomised, placebo‐controlled trial (184 citations)
  • Effect of liraglutide, a glucagon‐like peptide‐1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)—a multicentre, double‐blind, randomised, placebo‐controlled trial (184 citations)
  • Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes (137 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Diabetes mellitus

His main research concerns Internal medicine, Endocrinology, Cardiology, Adiponectin and Diabetes mellitus. Allan Flyvbjerg combines topics linked to Type 1 diabetes with his work on Internal medicine. His work deals with themes such as Nephrology, Transplantation and Insulin-like growth factor, which intersect with Endocrinology.

His studies examine the connections between Cardiology and genetics, as well as such issues in C-reactive protein, with regards to Subclinical infection, Atherosclerotic disease, Ischemic heart, Proportional hazards model and Peripheral. His Adiponectin study incorporates themes from Adipose tissue, Waist and Type 2 diabetes. His research integrates issues of Disease, Methylglyoxal, Kidney disease and Endothelial dysfunction in his study of Diabetes mellitus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

Lars Rydén;Eberhard Standl;Małgorzata Bartnik;Greet Van den Berghe.
European Heart Journal (2006)

2528 Citations

The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth

Hasnain M. Khandwala;Ian E. McCutcheon;Allan Flyvbjerg;Keith E. Friend.
Endocrine Reviews (2000)

1049 Citations

Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure

Caroline Kistorp;Jens Faber;Søren Galatius;Finn Gustafsson.
Circulation (2005)

697 Citations

The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women

Michelle N. Harvie;Mary Pegington;Mark P. Mattson;Jan Frystyk.
International Journal of Obesity (2011)

665 Citations

Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span.

Karen T. Coschigano;Amy N. Holland;Markus E. Riders;Edward O. List.
Endocrinology (2003)

659 Citations

Coordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exercise

Benjamin F. Miller;Jens L. Olesen;Mette Hansen;Simon Døssing.
The Journal of Physiology (2005)

582 Citations

Obesity and cancer risk: the role of the insulin-IGF axis.

Andrew G. Renehan;Jan Frystyk;Allan Flyvbjerg.
Trends in Endocrinology and Metabolism (2006)

499 Citations

From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.

Bieke F. Schrijvers;An S. De Vriese;Allan Flyvbjerg.
Endocrine Reviews (2004)

423 Citations

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population.

Amalia Gastaldelli;Michaela Kozakova;Kurt Højlund;Allan Flyvbjerg.
Hepatology (2009)

406 Citations

Mesenchymal stem cell ingrowth and differentiation on coralline hydroxyapatite scaffolds.

Tina Mygind;Maik Stiehler;Anette Baatrup;Haisheng Li.
Biomaterials (2007)

399 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing Allan Flyvbjerg

John J. Kopchick

John J. Kopchick

Ohio University - Lancaster

Publications: 150

Jan Frystyk

Jan Frystyk

Aarhus University

Publications: 115

Michael Kjaer

Michael Kjaer

University of Copenhagen

Publications: 98

Jens Otto Lunde Jørgensen

Jens Otto Lunde Jørgensen

Aarhus University Hospital

Publications: 96

Niels Møller

Niels Møller

Aarhus University Hospital

Publications: 90

Andrzej Bartke

Andrzej Bartke

Southern Illinois University School of Medicine

Publications: 77

Mark E. Cooper

Mark E. Cooper

Monash University

Publications: 58

Stuart M. Phillips

Stuart M. Phillips

McMaster University

Publications: 55

Hans Ørskov

Hans Ørskov

Aarhus University Hospital

Publications: 52

Moustapha Kassem

Moustapha Kassem

University of Southern Denmark

Publications: 49

Thor Ueland

Thor Ueland

Oslo University Hospital

Publications: 47

Peter Rossing

Peter Rossing

Steno Diabetes Center

Publications: 46

Lars Rydén

Lars Rydén

Karolinska Institute

Publications: 44

Peter Schjerling

Peter Schjerling

University of Copenhagen

Publications: 44

Massimo Volpe

Massimo Volpe

Sapienza University of Rome

Publications: 41

Something went wrong. Please try again later.